Treatment of rare subtypes of kidney cancer
At the International Kidney Cancer Symposium (IKCS) in North America [...]
ASCO GU 2022: Treatment of sarcomatoid kidney cancer with immunotherapy
Metastatic sarcomatoid clear cell RCC is an aggressive type of [...]
Immunotherapy combinations in the first-line treatment of metastatic sarcomatoid kidney cancer
A recent study looked at the efficacy and safety of [...]
ESMO 2021: Sarcomatoid and/or rhabdoid RCC treated with immune checkpoint inhibitors after surgery
Cytoreductive nephrectomy is the surgical removal of the tumour to reduce the number [...]
Cabozantinib in pretreated patients with sarcomatoid kidney cancer
Sarcomatoid renal cell carcinoma (sRCC) is a rare and aggressive form of [...]
ASCO 2021: Pembrolizumab plus axitinib continues to improve survival in kidney cancer
The KEYNOTE-426 study of the immune checkpoint inhibitor, pembrolizumab plus [...]
ASCO 2021: Nivolumab plus ipilimumab for the treatment of kidney cancer brain metastases
Brain metastases resulting from the spread of renal cell carcinoma [...]
Immune checkpoint inhibitors for sarcomatoid kidney cancer
Sarcomatoid renal cell carcinoma (sRCC) is a rare and aggressive [...]
Top stories from 2020 for kidney cancer
Dr Sumanta (Monty) Pal, Clinical Professor and Co-Director of the [...]
2020 top stories in kidney cancer
This article summarises the key breakthroughs in the treatment of [...]
